- Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal womenS J M Neele
Endocrinology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
Bone 30:599-603. 2002..Our results show that 5 years of treatment with either Ral or CEE did not protect against bone loss after 1 year of withdrawal of therapy, and that the rate of bone loss was not significantly different from that of placebo-treated women...
- Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal womenT Teerlink
Department of Clinical Chemistry, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Clin Sci (Lond) 105:67-71. 2003..Thus ERT with oral conjugated oestrogen, but not with raloxifene, significantly reduced plasma concentrations of the cardiovascular risk factor ADMA in healthy postmenopausal women...